Ascendis Pharma A/S (Nasdaq: ASND) today announced that a new pooled analysis showed sustained and clinically meaningful ...

Doctors often use 'renal failure' and 'kidney failure' interchangeably, both signifying a critical loss of kidney function.

Takeda presents new data showing mezagitamab sustained effect on kidney function 18 months after treatment in primary IgA nephropathy: Osaka, Japan Monday, November 10, 2025, 15:0 ...

Ascendis Pharma A/S (Nasdaq: ASND) today announced that its data showing sustained improvements in renal function, continued ...

The results of two large-scale studies demonstrate that sodium-glucose co-transporter 2 (SGLT2) inhibitors significantly ...

Kidneys are one of the most important organs of the body, that filter waste and toxins, and keep us healthy. With age, poor ...

Ticagrelor and aspirin is the preferred combination for reducing the risk of recurrent stroke in clopidogrel nonresponders, but according to post hoc analysis of the CHANCE-2 trial, patients with ...

Detailed price information for Alnylam Pharmaceuticals (ALNY-Q) from The Globe and Mail including charting and trades.

In the United States, the annual rate of growth in incident patients with end-stage kidney disease has slowed. However, patients selecting home dialysis for the first time increased 85.6% from 2007 to ...

New data show the therapy led to minimal changes in renal function, even after more than 8 years. New long-term data show that patients with Fabry disease who are treated with migalastat (Galafold) ...